Global regulation has always been an impediment in the healthcare industry says Amit Bakshi, CMD, Eris Lifescience.

The return ratios are quite astounding. Ex-cash return on capital as well as return on equity is in three digits, it is more than 100%.

The shareholders of the company plans to sell 28,875,000 equity shares.

Vineet Nayyar, C P Gurnani, Uday Kotak, V S S Mani are among the 17 finalists of EY's Entrepreneur Of The Year Awards, 2013.